Cardiovascular–Kidney–Metabolic Syndrome Age Derived From Routine Health Checkup and Claims Data ― Large-Scale Epidemiological Study ―
Background: The cardiovascular–kidney–metabolic (CKM) framework emphasizes the interplay of metabolic, renal, and cardiovascular abnormalities in cardiovascular disease risk. We aimed to develop a CKM syndrome age algorithm using routinely collected health checkup and claims data in Japan.
Authors
- Norihiko Takeda (ORCID: https://orcid.org/0000-0003-1023-6116)
- Yuta Suzuki (ORCID: https://orcid.org/0000-0002-9406-4691)
- Hidehiro Kaneko (ORCID: https://orcid.org/0000-0003-2553-6170)
- Norifumi Takeda (ORCID: https://orcid.org/0000-0003-4818-3347)
- Akira Okada (ORCID: https://orcid.org/0000-0001-6480-3388)
- Kaori Hayashi (ORCID: https://orcid.org/0000-0002-4923-1550)
- Takahiro Jimba (ORCID: https://orcid.org/0000-0002-3757-3959)
- Toshiyuki Ko (ORCID: https://orcid.org/0000-0002-9043-064X)
- Masachika Nishikawa
- Koichi Node
- Hideo Yasunaga
- Katsuhito Fujiu
- Hiroyuki Morita
- Atsushi Mizuno
- Tatsuhiko Azegami
Institutions
- Saga University (JP)
- Keio University (JP)
- St. Luke's International Hospital (JP)
- National Institute of Public Health (LA)
- The University of Tokyo (JP)
- International University of Health and Welfare (JP)
Publication Details
- Journal
- Circulation Journal
- Published
- 2026-08-27
- DOI
- https://doi.org/10.1253/circj.cj-26-0498
- Primary Topic
- Health Promotion and Cardiovascular Prevention
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Boston Scientific Corporation
- Boston Scientific Japan
- Boehringer Ingelheim Japan
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
- Novo Nordisk
- University of Tokyo
- Novartis Pharma
- Bayer Yakuhin
- Medtronic Japan
- Daiichi Sankyo Europe